Brain tumor detection is essential for early diagnosis and successful treatment, both of which can significantly enhance patient outcomes. To evaluate brain MRI scans and categorize them into four ...

Can brain structure predict human intelligence? T1-weighted structural brain magnetic resonance images (sMRI) have been correlated with intelligence. However, the population-level association does not ...

Overall, the study indicates that integrating deep learning models into radiological workflows can enhance both efficiency ...

Deep learning (DL) reconstructed knee magnetic resonance imaging (MRI) is diagnostically equivalent to conventional accelerated MRI for evaluating internal derangement of the knee in a clinical ...

A recent Radiology journal study assesses the power of a fully automated deep learning (DL) model to produce deterministic outputs for identifying clinically significant prostate cancer (csPCa). Study ...

The post-processing algorithm helps de-noise the images produced after Hyperfine's Swoop system performs a scan: It relies on brainlike artificial neural networks to clean up the images in small ...

JERUSALEM, June 22 (Xinhua) -- Researchers have developed an innovative AI-powered method to make cancer Magnetic Resonance Imaging (MRI) scans faster and more accurate, the Israel Institute of ...

AI medical imaging market is projected to exceed $20B by 2035. Generative models address class imbalances in medical imaging ...

Yes, getting FDA 510(k) clearance for your medical device is something to cheer about. But consider Arterys Inc. It just reported its eighth FDA clearance, this time for a next generation, deep ...

GE's AIR Recon DL software is now compatible with the PROPELLER scanning technique, which makes it easier to image areas of the body that typically move during the procedure. ((Getty/josefkubes)) GE ...

Geisinger St. Luke’s Hospital in Orwigsburg recently made an investment in MRI imaging technology, becoming the fifth hospital in the world to offer GE Healthcare’s Air Recon DL technology with MR30 ...

An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...